Augmedix

Who owns Augmedix now?

Commure completed its merger with Augmedix on 2 October 2024, paying $2.35 per share, about $139M, an offer announced in July 2024 (Nasdaq and Fierce Healthcare). Augmedix is a wholly owned Commure subsidiary and no longer trades under AUGX. Ian Shakil, who founded the company in 2012, is now Commure's Chief Strategy Officer.

The Augmedix site still says "Augmedix, a Commure company". The iOS listing for the live service is titled "Commure Ambient - Live" under the developer name Augmedix, Inc., and Commure markets its enterprise family as Commure Ambient AI.

What does it do?

Augmedix offers three service levels. Go is automated and self-service, with AI drafting notes for ambulatory and acute care across dozens of specialties. Assist adds an AI layer with specialist support. Live is full-service, with synchronous human documentation and point-of-care support (Vizient release, January 2025). The company also sells an emergency medicine app and oncology tuning.

A Vizient contract for ambient AI documentation took effect on 6 January 2025, and the same release claims integration with more than 50 EHRs. The Augmedix site names athenahealth, Epic, Oracle Cerner, MEDITECH, iKnowMed, eClinicalWorks and NextGen. The Vizient release names Epic, Oracle Health and MEDITECH among the 50 or more.

The site mentions HITRUST and HIPAA. It shows no SOC 2 report and claims no FDA status.

What do clinicians say?

No peer-reviewed study of Augmedix exists. Vendor material calls it strong in large health systems and in emergency medicine and oncology.

The one clinician comment we hold is negative. A poster on r/medicine (March 2024) wrote that they were "very dissatisfied with Augmedix" and that non-native English speakers were a "huge problem", adding that an acceptable HPI is not "The patient's presents with quiescent rheumatoid arthritis" and nothing else. That was the human-scribe service, offered at no extra cost, and it predates the Commure merger, so the service level may have changed.

How much does Augmedix cost?

Augmedix gives no price and sells by quote (as of October 2026). Third-party estimates are not Augmedix figures. RevCycleAI puts hybrid human-plus-AI services at about $300 to $700 or more per clinician per month. PhysicianAITools gives small practices about $299, medium about $499 and large groups over $699, within a wider range of $150 to $2,000. ITQlick's outlier of $20,000 to $40,000 per month for 10 users plus a $3,000 to $10,000 onboarding fee works out to about $2,000 to $4,000 per clinician per month. Those sources expect multi-year volume commitments, and pricing may now be bundled under Commure. For scale, Freed lists its unlimited-note plan at $79 per month.

How does it compare?

DAX Copilot, Abridge, Suki, Ambience, Nabla and Heidi are the usual alternatives, along with Commure's own scribe. Augmedix's differentiator is the human layer, and that is also where the one critical comment landed.

The verdict

Buy Augmedix if you want a human in the loop for documentation in a busy ED or an oncology clinic and you can negotiate an enterprise contract. Pilot it on a language-diverse set of clinicians first, given the report on non-native English speakers, and ask what the Live tier looks like after the Commure integration.